There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total annual sales of over $500 billion. The firms have developed and marketed most…
These are the top day trader and active trader alert stocks. We have more details and analysis via a link to each story over at VSInvestor.com: Apple Inc.(NASDAQ: AAPL) is one we…
Reuters: Kraft (NYSE:KFT) sold it pizza business to Nestle and lifted the cash portion of its deal to buy Cadbury (NYSE:CBY). Reuters: Cold weather pushed oil prices near $82. Reuters: US healthcare spending…
Reuters: China say data show the US tire tariffs are unfair. Reuters: A Fed policy debate has begun now that the recession is over. Reuters: The world’s wealth is down 11% and…
The rate at which unemployment is growing has slowed recently and is no longer running more than 700,000 jobs lost a month. But, the firings are continuing, even at America’s largest companies, a…
Douglas A. McIntyre Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a…
These are this Monday’s top day trader and active trader alert stocks. More detailed price and volume data is provided via a link to each story at VSInvestor.com: Freddie Mac (NYSE: FRE)…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis…
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest data suggest traders are now…
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s osteoporosis drug…
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –…
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down in drug…
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a brief…
These are some of the top analyst downgrades and cautious research calls we have seen from Wall Street early this Tuesday morning: Ansys (ANSS) Cut to Neutral from Overweight at JPMorgan. Cabot…
